BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pseudomonas infection
,
Lymphocyte
,
Avian flu virus
,
Doxycycline
,
rs3825942
,
FGF21
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
phosphodiesterase 6
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Broad Connectivity Map (CMAP 2.0) compound database
Livers of rat exposed to variety of hepatotoxic compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
Hippocampal synaptic plasticity in mice carrying the rd mutation in the gene encoding cGMP phosphodi…
Phosphodiesterase inhibitors block the acceleration of skin permeability barrier repair by red light…
Non-arteritic anterior ischemic optic neuropathy associated with erectile dysfunction medications].
Structural determinants of phosphodiesterase 6 response on binding catalytic site inhibitors.
Restoration of vision in the pde6β-deficient dog, a large animal model of rod-cone dystrophy.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phosphodiesterase Inhibitors in Glaucoma Study (PhiGS)
Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension
The Phosphodiesterase Inhibitor Pentoxifylline as an Adjuvant in Treatment of Negative Symptoms in C…
The Role of Phosphodiesterase Inhibitors in Incretin Secretion
Study of Add-on Ambrisentan Therapy to Background Phosphodiesterase Type-5 Inhibitor (PDE5i) Therapy…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ